Business Description
MediciNova Inc
NAICS : 325412
SIC : 2834
ISIN : US58468P2065
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 233.36 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 8.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.3 | |||||
3-Year EPS without NRI Growth Rate | 18.1 | |||||
3-Year FCF Growth Rate | 14.7 | |||||
3-Year Book Growth Rate | -7.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -11.37 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -40.31 | |||||
12-1 Month Momentum % | -40.79 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 18.25 | |||||
Quick Ratio | 18.25 | |||||
Cash Ratio | 17.78 | |||||
Days Sales Outstanding | 365 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.9 | |||||
Shareholder Yield % | 0.11 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -981.9 | |||||
Net Margin % | -816.5 | |||||
FCF Margin % | -844.61 | |||||
ROE % | -13.19 | |||||
ROA % | -12.51 | |||||
ROIC % | -63.45 | |||||
ROC (Joel Greenblatt) % | -1608.09 | |||||
ROCE % | -15.71 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 90.5 | |||||
PB Ratio | 1.55 | |||||
Price-to-Tangible-Book | 2.06 | |||||
EV-to-EBIT | -4.54 | |||||
EV-to-EBITDA | -4.55 | |||||
EV-to-Revenue | 44.63 | |||||
EV-to-FCF | -5.22 | |||||
Price-to-Net-Current-Asset-Value | 2.09 | |||||
Price-to-Net-Cash | 2.15 | |||||
Earnings Yield (Greenblatt) % | -22.03 | |||||
FCF Yield % | -9.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MediciNova Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.937 | ||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 40.5 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0.103071 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | -40.79 | ||
52-Week Range (€) | 2.672 - 10.5 | ||
Shares Outstanding (Mil) | 48.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MediciNova Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MediciNova Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
MediciNova Inc Frequently Asked Questions
What is MediciNova Inc(FRA:RMN)'s stock price today?
When is next earnings date of MediciNova Inc(FRA:RMN)?
Does MediciNova Inc(FRA:RMN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |